M
Maia Segura Wang
Publications - 2
Citations - 1906
Maia Segura Wang is an academic researcher. The author has contributed to research in topics: Cancer & Notch signaling pathway. The author has an hindex of 2, co-authored 2 publications receiving 1371 citations.
Papers
More filters
Journal ArticleDOI
Comprehensive genomic profiles of small cell lung cancer
Julie George,Jing Shan Lim,Se Jin Jang,Yupeng Cun,Luka Ozretić,Gu Kong,Frauke Leenders,Xin Lu,Lynnette Fernandez-Cuesta,Graziella Bosco,Christian Müller,Ilona Dahmen,Nadine Jahchan,Kwon-Sik Park,Dian Yang,Anthony N. Karnezis,Dedeepya Vaka,Ángela Torres,Maia Segura Wang,Jan O. Korbel,Roopika Menon,Sung-Min Chun,Deokhoon Kim,Matthew D. Wilkerson,Neil Hayes,David Engelmann,Brigitte M. Pützer,Marc Bos,Sebastian Michels,Ignacija Vlasic,Danila Seidel,Berit Pinther,Philipp Schaub,Christian Becker,Janine Altmüller,Jun Yokota,Takashi Kohno,Reika Iwakawa,Koji Tsuta,Masayuki Noguchi,Thomas Muley,Hans Hoffmann,Philipp A. Schnabel,Iver Petersen,Yuan Chen,Alex Soltermann,Verena Tischler,Chang-Min Choi,Yong-Hee Kim,Pierre P. Massion,Yong Zou,Dragana Jovanovic,Milica Kontic,Gavin M. Wright,Prudence A. Russell,Benjamin Solomon,Ina Koch,Michael Lindner,Lucia Anna Muscarella,Annamaria la Torre,John K. Field,Marko Jakopović,Jelena Knezevic,Esmeralda Castaños-Vélez,Luca Roz,Ugo Pastorino,O.T. Brustugun,Marius Lund-Iversen,Erik Thunnissen,Jens Köhler,Martin Schuler,Johan Botling,Martin Sandelin,Montserrat Sanchez-Cespedes,Helga B. Salvesen,Viktor Achter,Ulrich Lang,Magdalena Bogus,Peter M. Schneider,Thomas Zander,Sascha Ansén,Michael Hallek,Jürgen Wolf,Martin Vingron,Yasushi Yatabe,William D. Travis,Peter Nürnberg,Christian Reinhardt,Sven Perner,Lukas C. Heukamp,Reinhard Büttner,Stefan A. Haas,Elisabeth Brambilla,Martin Peifer,Julien Sage,Roman K. Thomas +95 more
TL;DR: This first comprehensive study of somatic genome alterations in SCLC uncovers several key biological processes and identifies candidate therapeutic targets in this highly lethal form of cancer.
Journal ArticleDOI
Atypical Teratoid/Rhabdoid Tumors Are Comprised of Three Epigenetic Subgroups with Distinct Enhancer Landscapes
Pascal Johann,Pascal Johann,Serap Erkek,Marc Zapatka,Kornelius Kerl,Ivo Buchhalter,Volker Hovestadt,David T.W. Jones,Dominik Sturm,Dominik Sturm,Carl Hermann,Maia Segura Wang,Andrey Korshunov,Andrey Korshunov,Marina Rhyzova,Susanne Gröbner,Sebastian Brabetz,Lukas Chavez,Susanne Bens,Stefan Gröschel,Fabian Kratochwil,Andrea Wittmann,Laura Sieber,Christina Geörg,Stefan Wolf,Katja Beck,Florian Oyen,David Capper,David Capper,Peter van Sluis,Richard Volckmann,Jan Koster,Rogier Versteeg,Andreas von Deimling,Andreas von Deimling,Till Milde,Till Milde,Olaf Witt,Olaf Witt,Andreas E. Kulozik,Martin Ebinger,Tarek Shalaby,Michael A. Grotzer,David Sumerauer,Josef Zamecnik,Jaume Mora,Nada Jabado,Michael D. Taylor,Annie Huang,Eleonora Aronica,Anna Marta Maria Bertoni,Bernhard Radlwimmer,Torsten Pietsch,Ulrich Schüller,Reinhard Schneppenheim,Paul A. Northcott,Jan O. Korbel,Reiner Siebert,Michael C. Frühwald,Michael C. Frühwald,Peter Lichter,Roland Eils,Amar Gajjar,Martin Hasselblatt,Stefan M. Pfister,Stefan M. Pfister,Marcel Kool +66 more
TL;DR: Three distinct molecular subgroups of ATRTs, associated with differences in demographics, tumor location, and type of SMARCB1 alterations, were identified, leading to the identification of subgroup-specific regulatory networks and potential therapeutic targets.